Novan logo

NOVN Novan

Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.

Healthcare Biotechnology SIC: Unknown CIK: 1467154

Auditor raised Going Concern issues

Transaction DateRecipientSharesTypePriceValue